Stay updated with breaking news from Bryan martins. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Evercore ISI initiated coverage on shares of 89bio (NASDAQ:ETNB – Get Rating) in a research report released on Tuesday, The Fly reports. The firm issued an outperform rating and a $49.00 price target on the stock. ETNB has been the topic of a number of other reports. HC Wainwright raised their price target on shares […] ....
SAN FRANCISCO, June 07, 2023 89bio, Inc. , a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and. | June 7, 2023 ....
SAN FRANCISCO, June 07, 2023 89bio, Inc. , a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and. | June 7, 2023 ....
Shares of 89bio, Inc. (NASDAQ:ETNB – Get Rating) have been assigned a consensus rating of “Buy” from the nine brokerages that are currently covering the stock, MarketBeat.com reports. Four research analysts have rated the stock with a buy rating. The average 1 year target price among brokerages that have issued a report on the stock […] ....
Shares of 89bio, Inc. (NASDAQ:ETNB – Get Rating) gapped down before the market opened on Tuesday . The stock had previously closed at $17.87, but opened at $17.00. 89bio shares last traded at $17.21, with a volume of 250,812 shares changing hands. Analyst Upgrades and Downgrades A number of equities research analysts have issued reports […] ....